Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

EDT Cathie Wood’s ARK Investment buys 115.5K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for ...

Shares of TXG opened at $7.14 on Tuesday. 10x Genomics has a 1 year low of $6.78 and a 1 year high of $37.74. The stock’s fifty day moving average price is $10.96 and its two-hundred day moving ...

PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will ...

10x Genomics, a company focused on accelerating discovery, today announced the launch of the Single Cell Mouse Immune Profiling Solution. For the first time, researchers will have the ability to ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, ...